Investors and Media
Stock Information
Price: $4.80   Change: + 0.53
Dec 19, 2014 4:00 PM ET
Investor Relations
Stock price graph

ZIOPHARM Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of new cancer therapies.

View all »   RSSRecent Releases

Dec 3, 2014
ZIOPHARM and Intrexon Present Clinical and Preclinical Data From Immuno-Oncology Programs at AACR Tumor Immunology and Immunotherapy Meeting

Oct 30, 2014
ZIOPHARM Reports Third-Quarter 2014 Financial Results

Jun 25, 2014 at 10:00 AM ET
JMP Securities Healthcare Conference

Mar 28, 2014 at 3:00 PM ET
21st Annual Future Leaders in the Biotech Industry Conference